If youre dragging, a bigger breakfast or a snack can assist
Cost, Insurance Driving Move to Compounded Drugs Compounded GLP-1 medications are not approved by the FDA, and the agency issued a warning in June calling them potentially "risky for patients." This hasn't stopped patients from switching to the unapproved drugs, and 35% of patients who took compounded GLP-1s left from a name brand drug, according to Gallup
The same thing happens to a peptide when it's exposed to harsh conditions like heat, agitation, or even light
The National Institute for Health and Care Excellence (NICE) recommends GLP-1 receptor agonists for adults with type 2 diabetes when metformin and other oral therapies have not achieved adequate glycaemic control
[1] Retatrutide combines agonism at the GLP-1, GIP, and glucagon receptors, while Tirzepatide targets only the GLP-1 and GIP receptors